Literature DB >> 22737416

The effect of cabergoline on clinical and laboratory findings in active rheumatoid arthritis.

M Mobini1, Z Kashi, A R Mohammad Pour, E Adibi.   

Abstract

Entities:  

Keywords:  Cabergoline; Dopamine agonist; Prolactin; Rheumatoid arthritis

Year:  2011        PMID： 22737416      PMCID： PMC3371879     

Source DB:  PubMed          Journal:  Iran Red Crescent Med J        ISSN： 2074-1804            Impact factor:   0.611


× No keyword cloud information.
  11 in total

1.  Treatment of rheumatoid arthritis with the dopamine agonist quinagolide.

Authors:  A Eijsbouts; F van den Hoogen; R F Laan; R M Hermus; F C Sweep; L van de Putte
Journal:  J Rheumatol       Date:  1999-10       Impact factor: 4.666

2.  Control of unremitting rheumatoid arthritis by the prolactin antagonist cabergoline.

Authors:  N Erb; A V Pace; J P Delamere; G D Kitas
Journal:  Rheumatology (Oxford)       Date:  2001-02       Impact factor: 7.580

Review 3.  Prolactin and autoimmunity.

Authors:  Annamaria De Bellis; Antonio Bizzarro; Rosario Pivonello; Gaetano Lombardi; Antonio Bellastella
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

4.  Bromocriptine induces immunological changes related to disease parameters in rheumatoid arthritis.

Authors:  F E Figueroa; F Carrión; M E Martínez; S Rivero; I Mamani
Journal:  Br J Rheumatol       Date:  1997-09

5.  Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural, and morphometric study.

Authors:  G T Tindall; K Kovacs; E Horvath; M O Thorner
Journal:  J Clin Endocrinol Metab       Date:  1982-12       Impact factor: 5.958

6.  Prolactin locally produced by synovium infiltrating T lymphocytes induces excessive synovial cell functions in patients with rheumatoid arthritis.

Authors:  H Nagafuchi; N Suzuki; A Kaneko; T Asai; T Sakane
Journal:  J Rheumatol       Date:  1999-09       Impact factor: 4.666

Review 7.  Rheumatoid arthritis.

Authors:  D M Lee; M E Weinblatt
Journal:  Lancet       Date:  2001-09-15       Impact factor: 79.321

8.  [Bromocriptine for refractory rheumatoid arthritis].

Authors:  R Mader
Journal:  Harefuah       Date:  1997-12-01

9.  Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.

Authors:  David W McCarey; Iain B McInnes; Rajan Madhok; Rosie Hampson; Olga Scherbakov; Ian Ford; Hilary A Capell; Naveed Sattar
Journal:  Lancet       Date:  2004-06-19       Impact factor: 79.321

10.  A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group.

Authors:  J Webster; G Piscitelli; A Polli; C I Ferrari; I Ismail; M F Scanlon
Journal:  N Engl J Med       Date:  1994-10-06       Impact factor: 91.245
View more
  9 in total

Review 1.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

Review 2.  Dopaminergic Pathways in Obesity-Associated Inflammation.

Authors:  Fernanda Leite; Laura Ribeiro
Journal:  J Neuroimmune Pharmacol       Date:  2019-07-17       Impact factor: 4.147

Review 3.  Dopaminergic Regulation of Innate Immunity: a Review.

Authors:  Monica Pinoli; Franca Marino; Marco Cosentino
Journal:  J Neuroimmune Pharmacol       Date:  2017-06-03       Impact factor: 4.147

4.  Construction of a ceRNA Network Related to Rheumatoid Arthritis.

Authors:  Zhanya Huang; Nanzhen Kuang
Journal:  Genes (Basel)       Date:  2022-04-06       Impact factor: 4.141

Review 5.  The role of the prolactin/vasoinhibin axis in rheumatoid arthritis: an integrative overview.

Authors:  Carmen Clapp; Norma Adán; María G Ledesma-Colunga; Mariana Solís-Gutiérrez; Jakob Triebel; Gonzalo Martínez de la Escalera
Journal:  Cell Mol Life Sci       Date:  2016-03-29       Impact factor: 9.261

Review 6.  The dopaminergic system in autoimmune diseases.

Authors:  Rodrigo Pacheco; Francisco Contreras; Moncef Zouali
Journal:  Front Immunol       Date:  2014-03-21       Impact factor: 7.561

Review 7.  Immunomodulatory Effects Mediated by Dopamine.

Authors:  Rodrigo Arreola; Samantha Alvarez-Herrera; Gilberto Pérez-Sánchez; Enrique Becerril-Villanueva; Carlos Cruz-Fuentes; Enrique Octavio Flores-Gutierrez; María Eugenia Garcés-Alvarez; Dora Luz de la Cruz-Aguilera; Emilio Medina-Rivero; Gabriela Hurtado-Alvarado; Saray Quintero-Fabián; Lenin Pavón
Journal:  J Immunol Res       Date:  2016-10-04       Impact factor: 4.818

Review 8.  Dopaminergic Agents in Rheumatoid Arthritis.

Authors:  Silvia Capellino
Journal:  J Neuroimmune Pharmacol       Date:  2019-04-23       Impact factor: 4.147

9.  Dopaminergic Receptors and Tyrosine Hydroxylase Expression in Peripheral Blood Mononuclear Cells: A Distinct Pattern in Central Obesity.

Authors:  Fernanda Leite; Margarida Lima; Franca Marino; Marco Cosentino; Laura Ribeiro
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.